Literature DB >> 12060530

Function and mechanism of pyronaridine: a new inhibitor of P-glycoprotein-mediated multidrug resistance.

Jing Qi1, Chun-Zheng Yang, Cai-Yun Wang, Shu-Bin Wang, Ming Yang, Jin-Hong Wang.   

Abstract

AIM: To study the effect and mechanism of pyronaridine (PND) on the reversal of multidrug resistance (MDR) in K562/A02 and MCF7/ADR cell lines with mdr1+.
METHODS: MTT assay was used to determine the cells growth inhibition after incubation for 72 h in the presence of doxorubicin (DOX) with or without PND. Intracellular accumulation of DOX was analyzed by spectrofluorometry. P-glycoprotein (P-gp) activity was investigated by measuring the extrusion of the cationic dye rhodamine 123 (Rh123). The apoptosis of cells and mdr1 gene expression were detected using flow cytometry and RTPCR, respectively.
RESULTS: PND slightly inhibited the growth of MDR human leukemia, breast cancer cells, and their parental cell lines. The IC50 of PND were 5.10 - 18.66 micromol/L depending on the kinds of cell lines. PND at low toxic concentrations enhanced antiproliferative effect of DOX on MDR cells and the apoptosis induced by DOX in a concentration-dependent manner. Intracellular accumulation of DOX and Rh123 in MDR cell lines increased after combination with PND. PND did not down-regulate mdr1 gene expression in MDR cell lines K562/A02 and MCF7/ADR.
CONCLUSION: As the third-generation Pgp inhibitor, PND significantly reversed MDR in MDR cell lines K562/A02 and MCF7/ADR by inhibiting P-gp function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12060530

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  11 in total

1.  Role of P glycoprotein in absorption of novel antimalarial drugs.

Authors:  Andrew Crowe; Kenneth F Ilett; Harin A Karunajeewa; Kevin T Batty; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2006-08-17       Impact factor: 5.191

Review 2.  Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies.

Authors:  Chung-Pu Wu; Anna Maria Calcagno; Suresh V Ambudkar
Journal:  Curr Mol Pharmacol       Date:  2008-06       Impact factor: 3.339

3.  Prostate Apoptosis Response-4 (Par-4): A Novel Target in Pyronaridine-Induced Apoptosis in Glioblastoma (GBM) Cells.

Authors:  Jeevan Ghosalkar; Vinay Sonawane; Tejal Pisal; Swati Achrekar; Radha Pujari; Ashish Chugh; Padma Shastry; Kalpana Joshi
Journal:  Cancers (Basel)       Date:  2022-06-29       Impact factor: 6.575

4.  Inhibition of MDR1 activity and induction of apoptosis by analogues of nifedipine and diltiazem: an in vitro analysis.

Authors:  Maurizio Viale; Cinzia Cordazzo; Daniela de Totero; Roberta Budriesi; Camillo Rosano; Alberto Leoni; Pierfranco Ioan; Cinzia Aiello; Michela Croce; Aldo Andreani; Mirella Rambaldi; Patrizia Russo; Alberto Chiarini; Domenico Spinelli
Journal:  Invest New Drugs       Date:  2009-10-30       Impact factor: 3.850

Review 5.  Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria.

Authors:  Hasifa Bukirwa; B Unnikrishnan; Christine V Kramer; David Sinclair; Suma Nair; Prathap Tharyan
Journal:  Cochrane Database Syst Rev       Date:  2014-03-04

6.  Absence of association between pyronaridine in vitro responses and polymorphisms in genes involved in quinoline resistance in Plasmodium falciparum.

Authors:  Bruno Pradines; Sébastien Briolant; Maud Henry; Claude Oeuvray; Eric Baret; Rémy Amalvict; Eric Didillon; Christophe Rogier
Journal:  Malar J       Date:  2010-11-25       Impact factor: 2.979

7.  Drug-drug interaction analysis of pyronaridine/artesunate and ritonavir in healthy volunteers.

Authors:  Carrie A Morris; Luis Lopez-Lazaro; Donald Jung; Janthima Methaneethorn; Stephan Duparc; Isabelle Borghini-Fuhrer; Rolf Pokorny; Chang-Sik Shin; Lawrence Fleckenstein
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

8.  ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal.

Authors:  Cheol-Hee Choi
Journal:  Cancer Cell Int       Date:  2005-10-04       Impact factor: 5.722

9.  Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infection.

Authors:  Kay Seden; Sara Gibbons; Catia Marzolini; Jonathan M Schapiro; David M Burger; David J Back; Saye H Khoo
Journal:  PLoS One       Date:  2017-03-23       Impact factor: 3.240

10.  Transcriptome analysis uncovers the key pathways and candidate genes related to the treatment of Echinococcus granulosus protoscoleces with the repurposed drug pyronaridine.

Authors:  Yingfang Yu; Jun Li; Weisi Wang; Tian Wang; Wenjing Qi; Xueting Zheng; Lei Duan; Jiaxu Chen; Shizhu Li; Xiumin Han; Wenbao Zhang; Liping Duan
Journal:  BMC Genomics       Date:  2021-07-13       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.